ARDD 2026 signals a new era for longevity biotechnology as frontier AI, big pharma, and scientific pioneers converge at Harvard
Business Announcement
Updates every hour. Last Updated: 31-Oct-2026 02:15 ET (31-Oct-2026 06:15 GMT/UTC)
Founded in 2014 by Alex Zhavoronkov, PhD, Founder and Co-CEO of Insilico Medicine, ARDD made its North American debut in Boston following years of growth in Europe. What began as an academically focused scientific gathering has evolved into a global forum connecting fundamental aging biology with the computational power, industrial capabilities, and investment needed to advance a new generation of longevity technologies.
A new review examines how the gut microbiota interacts with radiotherapy. Radiation can disrupt intestinal bacteria and metabolism, while microbial communities and their metabolites may influence tumor radiosensitivity and radiation-induced intestinal injury. The authors discuss microbiota-targeted strategies, including probiotics, dietary interventions and traditional Chinese medicine (TCM)-derived compounds, while emphasizing the need for further clinical evidence.
NUS Medicine-led review of more than 550,000 women finds earlier menopause and a higher number of births were associated with modestly greater biological age acceleration, offering new insights into women’s health and healthy longevity